Penn has reached an agreement to resolve a dispute over Covid-19 royalties the Philadelphia university alleged it was owed.
The new $467 million includes $400 million in royalties for the Pfizer-BioNTech vaccine from 2020 through 2023.
The German drugmaker will pay the NIH $791.5 million, while the University of Pennsylvania will get up to $467 million ...
BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University ...
Seeking Alpha on MSN8d
BioNTech inks $1B settlements with NIH and Penn to resolve COVID vaccine royalty claimsBioNTech (BNTX) stock slipped after signing $1B deals with NIH and the University of Pennsylvania to resolve COVID vaccine ...
German pharmaceutical company BioNTech has agreed to pay a combined sum of more than $1.2 billion to resolve separate ...
The University of Pennsylvania expects to receive $467 million from a German COVID-19 vaccine manufacturer after the pair ...
BUCKSCO.Today on MSN18h
BioNTech Agrees to Pay $467M to Penn as Part of COVID-19 Vaccine Royalties SettlementUniversity of Pennsylvania will receive $467 million from BioNTech as part of a settlement in a lawsuit over COVID-19 vaccine ...
DPA International on MSN8d
BioNTech and Pfizer to pay Covid-19 vaccine settlements in USThe German pharmaceutical company BioNTech announced on Friday that it has reached settlements in the US to resolve a ...
BioNTech (BNTX) has reached settlement agreements with the U.S. National Institutes of Health (NIH) and the University of Pennsylvania over royalties tied to its COVID-19 vaccine, resolving ...
A third dose of COVID-19 vaccine is beneficial among older Medicare beneficiaries, regardless of prior medically attended COVID-19 diagnoses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback